Skip to main content
. 2022 Nov 11;15:2437–2443. doi: 10.2147/CCID.S391944

Figure 1.

Figure 1

Erythema, chapped, and lichenoid lesions in patient eight before dupilumab treatment (A). After the treatment, the body lesions were significantly improved, and the redness and dryness of the lips were reduced (B).